Iovance Biotherapeutics (IOVA) Shares Outstanding (2010 - 2026)

Iovance Biotherapeutics (IOVA) has reported Shares Outstanding (Entity) for 17 consecutive years, with $418511.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 29.62% year-over-year to $418511.0; the TTM figure through Mar 2026 stood at $418511.0 (up 29.62% YoY), while the FY2025 annual figure was $357345.0, up 23.27% from the prior year.
• Shares Outstanding (Entity) rose to $418511.0 in Q1 2026 per IOVA's latest filing, from $357345.0 in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $279.8 million in Q1 2024 and bottomed at $157113.0 in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $76.7 million across 5 years, with a median of $357345.0 in 2025.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) soared 142701.03% — and 2025, when it slumped 99.88%.
• Iovance Biotherapeutics' Shares Outstanding (Entity) stood at $159259.0 in 2022, then soared by 47.64% to $235131.0 in 2023, then climbed by 23.28% to $289877.0 in 2024, then rose by 23.27% to $357345.0 in 2025, then increased by 17.12% to $418511.0 in 2026.
• Business Quant data shows IOVA's Shares Outstanding (Entity) at $418511.0 in Q1 2026, $357345.0 in Q4 2025, and $364037.0 in Q3 2025.